BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20054657)

  • 21. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.
    Janoueix-Lerosey I; Lequin D; Brugières L; Ribeiro A; de Pontual L; Combaret V; Raynal V; Puisieux A; Schleiermacher G; Pierron G; Valteau-Couanet D; Frebourg T; Michon J; Lyonnet S; Amiel J; Delattre O
    Nature; 2008 Oct; 455(7215):967-70. PubMed ID: 18923523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wilms tumor genes.
    Huff V; Saunders GF
    Biochim Biophys Acta; 1993 Dec; 1155(3):295-306. PubMed ID: 8268188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors.
    McDonald JM; Douglass EC; Fisher R; Geiser CF; Krill CE; Strong LC; Virshup D; Huff V
    Cancer Res; 1998 Apr; 58(7):1387-90. PubMed ID: 9537236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-wide linkage analysis to identify genetic modifiers of ALK mutation penetrance in familial neuroblastoma.
    Devoto M; Specchia C; Laudenslager M; Longo L; Hakonarson H; Maris J; Mossé Y
    Hum Hered; 2011; 71(2):135-9. PubMed ID: 21734404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors.
    O'Keefe D; Dao D; Zhao L; Sanderson R; Warburton D; Weiss L; Anyane-Yeboa K; Tycko B
    Am J Hum Genet; 1997 Aug; 61(2):295-303. PubMed ID: 9311733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multifocal primary neuroblastoma tumor heterogeneity in siblings with co-occurring PHOX2B and NF1 genetic aberrations.
    Rybinski B; Wolinsky T; Brohl A; Moerdler S; Reed DR; Ewart M; Weiser D
    Genes Chromosomes Cancer; 2020 Feb; 59(2):119-124. PubMed ID: 31515834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel familial WT1 read-through mutation associated with Wilms tumor and slow progressive nephropathy.
    Zirn B; Wittmann S; Gessler M
    Am J Kidney Dis; 2005 Jun; 45(6):1100-4. PubMed ID: 15957141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients.
    Nordenskjöld A; Friedman E; Sandstedt B; Söderhäll S; Anvret M
    Int J Cancer; 1995 Nov; 63(4):516-22. PubMed ID: 7591260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population-based risk estimates of Wilms tumor in sporadic aniridia. A comprehensive mutation screening procedure of PAX6 identifies 80% of mutations in aniridia.
    Grønskov K; Olsen JH; Sand A; Pedersen W; Carlsen N; Bak Jylling AM; Lyngbye T; Brøndum-Nielsen K; Rosenberg T
    Hum Genet; 2001 Jul; 109(1):11-8. PubMed ID: 11479730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in the transcriptional repressor REST predispose to Wilms tumor.
    Mahamdallie SS; Hanks S; Karlin KL; Zachariou A; Perdeaux ER; Ruark E; Shaw CA; Renwick A; Ramsay E; Yost S; Elliott A; Birch J; Capra M; Gray J; Hale J; Kingston J; Levitt G; McLean T; Sheridan E; Renwick A; Seal S; Stiller C; Sebire N; Westbrook TF; Rahman N
    Nat Genet; 2015 Dec; 47(12):1471-4. PubMed ID: 26551668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q.
    Murphy AJ; Cheng C; Williams J; Shaw TI; Pinto EM; Dieseldorff-Jones K; Brzezinski J; Renfro LA; Tornwall B; Huff V; Hong AL; Mullen EA; Crompton B; Dome JS; Fernandez CV; Geller JI; Ehrlich PF; Mulder H; Oak N; Maciezsek J; Jablonowski CM; Fleming AM; Pichavaram P; Morton CL; Easton J; Nichols KE; Clay MR; Santiago T; Zhang J; Yang J; Zambetti GP; Wang Z; Davidoff AM; Chen X
    Nat Commun; 2023 Dec; 14(1):8006. PubMed ID: 38110397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline mutations in the PAF1 complex gene CTR9 predispose to Wilms tumour.
    Hanks S; Perdeaux ER; Seal S; Ruark E; Mahamdallie SS; Murray A; Ramsay E; Del Vecchio Duarte S; Zachariou A; de Souza B; Warren-Perry M; Elliott A; Davidson A; Price H; Stiller C; Pritchard-Jones K; Rahman N
    Nat Commun; 2014 Aug; 5():4398. PubMed ID: 25099282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular genetics of Wilms' tumour.
    Tay JS
    J Paediatr Child Health; 1995 Oct; 31(5):379-83. PubMed ID: 8554853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for genetic heterogeneity in familial Wilms' tumor.
    Huff V; Amos CI; Douglass EC; Fisher R; Geiser CF; Krill CE; Li FP; Strong LC; McDonald JM
    Cancer Res; 1997 May; 57(10):1859-62. PubMed ID: 9157975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors.
    Ruteshouser EC; Robinson SM; Huff V
    Genes Chromosomes Cancer; 2008 Jun; 47(6):461-70. PubMed ID: 18311776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypic characteristics of Wilms' tumour attributable to FWT1.
    Rahman N; Abidi F; Ford D; Arbour L; Rapley E; Tonin P; Barton D; Batcup G; Berry J; Cotter F; Davison V; Gerrard M; Gray E; Grundy R; Hanafy M; King D; Lewis I; Ridolfi Luethy A; Madlensky L; Mann J; O'Meara A; Oakhill T; Skolnick M; Strong L; Stratton MR
    Hum Genet; 1998 Nov; 103(5):547-56. PubMed ID: 9860296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and functional consequence of PHOX2B mutations in neuroblastoma.
    Raabe EH; Laudenslager M; Winter C; Wasserman N; Cole K; LaQuaglia M; Maris DJ; Mosse YP; Maris JM
    Oncogene; 2008 Jan; 27(4):469-76. PubMed ID: 17637745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wilms tumor genetics.
    Huff V
    Am J Med Genet; 1998 Oct; 79(4):260-7. PubMed ID: 9781905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour.
    Scott RH; Stiller CA; Walker L; Rahman N
    J Med Genet; 2006 Sep; 43(9):705-15. PubMed ID: 16690728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pathophysiology of bilateral and multifocal Wilms tumors: What we can learn from the study of predisposition syndromes.
    Welter N; Brzezinski J; Treece A; Chintagumpala M; Young MD; Perotti D; Kieran K; Jongmans MCJ; Murphy AJ
    Pediatr Blood Cancer; 2023 May; 70 Suppl 2():e29984. PubMed ID: 36094328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.